Product Information
CLONAZEPAM 0.5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0199 per EA under NDC 00904722761. Its NADAC has been published 179 times since Jan 25, 2023.
Strength
.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904722761
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856On Market Since
8/23/2022
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG TABLET has been published 179 times since Jan 25, 2023, and over the history we have for it it has declined 18.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0199 per EA |
|---|---|
| All-time high | $0.0302 (Jul 12, 2023) |
| All-time low | $0.0174 (Nov 20, 2024) |
| 52-week high | $0.0224 |
| 52-week low | $0.0198 |
| Median price | $0.0222 |
| Average price | $0.0235 |
| Largest weekly change | -34.1% (Nov 20, 2024) |
| Weeks tracked | 179 |
| Tracking since | Jan 25, 2023 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0199 per EA (NDC 00904722761), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG TABLET has declined 18.7%. It has been tracked across 179 weekly CMS publications since Jan 25, 2023.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG TABLET?
Since Jan 25, 2023, the NADAC for CLONAZEPAM 0.5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0302 (Jul 12, 2023), with a median of $0.0222 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as CLONAZEPAM 0.5 MG TABLET, but none are currently priced below it.
Who manufactures CLONAZEPAM 0.5 MG TABLET?
CLONAZEPAM 0.5 MG TABLET (NDC 00904722761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification